EUVIMEDEUVIMED entdecken
Crossref

Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG

Merve Yoldas Celik iD, Havva Yazici iD, Fehime Erdem, Ayse Yuksel Yanbolu, Ayca Aykut, Asude Durmaz, Selcan Zeybek, Ebru Canda, Sema Kalkan Ucar iD, Mahmut Coker

Journal of Pediatric Endocrinology and Metabolism · 2023

DOI: 10.1515/jpem-2022-0641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2023. Verfasst von Merve Yoldas Celik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Metabolism and Nutrition, Ege University Faculty of Medicine, Izmir, Türkiye. Hauptthemen laut MEDLINE: Congenital Disorders of Glycosylation, Agammaglobulinemia, Hypoglycemia, N-Acetylgalactosaminyltransferases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Congenital Glycosylation Disorders (CDG) are a large group of inherited metabolic diseases with multi-organ involvement. Herein, we aimed to expand the clinical characteristics of patients with CDG based on our experience with diagnoses and follow-up of CDG patients from different subtypes.

Methods

The clinical and laboratory findings from the last 15 years were reviewed retrospectively in Ege University Child Metabolism and Nutrition Department.

Results

There were 8 (57.2 %) females and 6 (42.8 %) males. Diagnoses of the patients were PMM2-CDG (n=4), PGM1-CDG (n=2), DPAGT1-CDG (n=2), SRD5A3-CDG (n=2), MPI-CDG (n=1), POMT2-CDG (n=1), B3GALNT2-CDG (n=1), DPM1-CDG (n=1). The clinical findings of the patients were dysmorphia (85.7 %), developmental delay (85.7 %), intellectual disability (85.7 %), ocular abnormalities (64.2 %), skeletal malformations (64.2 %), failure to thrive (57.1 %), microcephaly (57.1 %), hepatomegaly (35.7 %), hearing loss (35.7 %), seizures (28.5 %), gastrointestinal symptoms (21.4 %), endocrine abnormalities (21.4 %), and cardiac abnormalities (7.1 %). Laboratory findings were abnormal TIEF (92.8 %), abnormal liver enzymes (64.2 %), decreased protein C (64.2 %), decreased antithrombin III (64.2 %), decreased protein S (42.8 %), hypogammaglobulinemia (35.7 %), cerebellar hypoplasia (28.5 %), CK elevation (7.1 %), and hypoglycemia (7.1 %).

Conclusions

This study contributes to the literature by sharing our ultra-rare DPM1-CDG case with less than 20 cases in the literature and expanding the clinical and molecular characteristics of other CDG patients. Hyperinsulinemic hypoglycemia, short stature, hypothyroidism, growth hormone deficiency, hypogammaglobulinemia, pericardial effusion, elevated CK, congenital myasthenia, and anorectal malformation were unique findings that were observed. Cerebello-ocular findings accompanying multi-organ involvement were an essential clue for a possible CDG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Congenital Disorders of GlycosylationAgammaglobulinemiaHypoglycemiaN-AcetylgalactosaminyltransferasesMaleChildFemaleHumansFollow-Up StudiesRetrospective StudiesGlycosylationMembrane Proteins3-Oxo-5-alpha-Steroid 4-Dehydrogenase

Stichwörter der Autor:innen

B3GALNT2CDGDPAGT1DPM1POMT2SRD5A3

Substanzen

SRD5A3 protein, humanMembrane Proteins3-Oxo-5-alpha-Steroid 4-DehydrogenaseB3GALNT2 protein, humanN-Acetylgalactosaminyltransferases

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Metabolism and Nutrition, Ege University Faculty of Medicine, Izmir, Türkiye.
  • Department of Genetics, Ege University Faculty of Medicine, Izmir, Türkiye.
  • Department of Genetics, Tinaztepe University Faculty of Medicine, Izmir, Türkiye.

ORCID-Profile: Merve Yoldas Celik, Havva Yazici, Sema Kalkan Ucar

Zitieren

APA

Yoldas Celik, M., Yazici, H., Erdem, F., Yuksel Yanbolu, A., Aykut, A., Durmaz, A., Zeybek, S., Canda, E., Kalkan Ucar, S., & Coker, M. (2023). Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2022-0641

Vancouver

Yoldas Celik M, Yazici H, Erdem F, Yuksel Yanbolu A, Aykut A, Durmaz A, et al. Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG. Journal of Pediatric Endocrinology and Metabolism. 2023. doi:10.1515/jpem-2022-0641

BibTeX
@article{YoldasCelik2023,
  author = {Yoldas Celik, Merve and Yazici, Havva and Erdem, Fehime and Yuksel Yanbolu, Ayse and Aykut, Ayca and Durmaz, Asude and Zeybek, Selcan and Canda, Ebru and Kalkan Ucar, Sema and Coker, Mahmut},
  title = {Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2023},
  doi = {10.1515/jpem-2022-0641}
}
Kostenlos starten →